PROFProfound Medical Corp.
6.790USDMkt Cap: 248.06M $P/E: —3d ago
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The compa…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap248.06M $
Enterprise Value227.76M $
Revenue (TTM)19.09M $
Gross Profit11.39M $
Net Income (TTM)-42.57M $
Revenue/Share0.5720 USD
Last Price6.790 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees162
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.31
PEG—
EV/EBITDA-6.53
EV/Revenue11.93
P/S12.73
P/B4.88
EPS (TTM)-0.93
EPS (Forward)-0.59
52W Range
6.52582% of range6.850
52W High6.850 USD
52W Low6.525 USD
Profitability
Gross Margin70.77%
Oper. Margin-445.67%
EBITDA Margin-182.74%
Profit Margin-264.44%
ROE-64.08%
ROA-54.95%
Growth
Revenue Growth12.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-38.21M $
CapEx (TTM)242.00K $
FCF Margin-130.04%
FCF Yield-10.01%
Net Debt-30.89M $
Net Debt/EBITDA0.89
Balance Sheet
Debt/Equity0.07
Current Ratio6.46
Quick Ratio5.25
Book Value/Sh1.363 USD
Cash/Share1.048 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 16, 2019
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.14 USD
Upside (mean)+64.1%
Target Range10.00 USD – 12.00 USD
$10.00+64.1% to mean$12.00
# Analysts5
Ownership
Shares Out.36.53M
Float35.45M
Insiders4.08%
Institutions45.25%
Short Interest
Short Ratio16.2d
Short % Float5.62%
Short % Out.4.97%
Shares Short1.80M
Short (prev mo.)2.07M
Technical
SMA 507.018 (-3.2%)
SMA 2006.865 (-1.1%)
Beta0.53
S&P 52W Chg21.00%
Avg Vol (30d)74.84K
Avg Vol (10d)123.64K
Technical Indicators
RSI (14)44.6
MACD-0.1008
MACD Signal-0.0172
MACD Hist.-0.0835
BB Upper8.311 USD
BB Middle7.250 USD
BB Lower6.190 USD
BB Width29.25%
ATR (14)0.4498 USD
Vol Ratio (20d)0.50x